Stockreport

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma [Yahoo! Finance]

Immunocore Holdings plc - American Depositary Shares  (IMCR) 
PDF (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 11 December 2024) The European Organisation for Research and Treatment of Cancer (EORTC), an independe [Read more]